GlassScriptPhysician profile
Mohammad Issa Alghrouz
NPI 1184983686
$11,162.58
in general payments reported to CMS, 2019-2025
34 companies · $3,128 in 2025
The $3,128 reported for 2025 was more than what 89% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $610 · 2020: $203 · 2021: $383 · 2022: $1,960 · 2023: $2,885 · 2024: $1,993 · 2025: $3,128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,063 · Travel and Lodging: $3,944.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,062.83 |
| Travel and Lodging | $3,943.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,225.27 | 2022-2025 | Xience Skypoint, Quadra Allure Mp, Perclose Proglide |
| Boston Scientific Corporation | $1,000.91 | 2019-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor, Bodyguardian |
| Cardiovascular Systems INC. | $828.84 | 2022 | |
| Medtronic, INC. | $798.89 | 2023 | Micra |
| Novartis Pharmaceuticals Corporation | $315.47 | 2023-2025 | |
| Abiomed | $281.73 | 2022-2024 | Impella |
| Janssen Pharmaceuticals, INC | $270.83 | 2019-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $258.82 | 2022-2025 | Verquvo, Capvaxive, Lagevrio |
| Amgen INC. | $257.94 | 2021-2025 | Repatha, Repatha |
| Pfizer INC. | $223.29 | 2019-2025 | |
| Edwards Lifesciences Corporation | $168.90 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $157.15 | 2021-2025 | Eliquis, Camzyos |
| Shockwave Medical, INC | $153.07 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $148.86 | 2020-2025 | Lifevest |
| Inari Medical, INC. | $136.07 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $126.72 | 2021-2022 | |
| Penumbra, INC. | $111.50 | 2021 | |
| Baxter Healthcare | $98.50 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Biotronik INC. | $94.90 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $73.10 | 2023-2024 | Inpefa |
| Inspire Medical Systems, INC. | $62.83 | 2023 | Inspire |
| Stryker Corporation | $53.28 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Esperion Therapeutics, INC. | $50.13 | 2021-2023 | Nexletol |
| Cleerly, INC. | $40.26 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Kestra Medical Technology Services, INC. | $37.88 | 2025 | Assure Wcd |
| Angiodynamics, INC. | $35.64 | 2025 | Auryon Laser System 100-120 Vac |
| Sanofi-Aventis U.S. LLC | $29.04 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.71 | 2019 | |
| Cagent Vascular INC | $22.44 | 2025 | Serrantor |
| Convatec INC. | $17.54 | 2023 | |
| Tactile Systems Technology INC | $17.35 | 2023 | Entre Plus, Flexitouch Plus |
| Medicomp INC | $16.39 | 2024 | Telepatch Cardiac Monitor |
| Astrazeneca Pharmaceuticals LP | $16.13 | 2024 | Farxiga |
| Heartflow, INC. | $10.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Alghrouz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.